SCHEMBL26112897

SCHEMBL26112897

CC(C)(C)C1N(c2nnc(Br)s2)CC12CCN(C(=O)O)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15876618 0.71 CYP2C19 (0.39) —
SCHEMBL25270430 0.71 — —
SCHEMBL16430906 0.70 PANK3 (0.32) —
SCHEMBL16432477 0.70 GPR119 (0.38) —
SCHEMBL15876548 0.67 GLS (0.38) —
SCHEMBL17925061 0.67 PANK3 (0.42) —
SCHEMBL25277206 0.65 — —
SCHEMBL28795276 0.65 HTR4 (0.32) —
SCHEMBL17925019 0.64 PCSK9 (0.31) —
SCHEMBL17925116 0.64 GPR119 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117157298-A Dual-function chimeric heterocyclic compound of interleukin-1 receptor related kinase 4, preparation method, medicinal composition and application thereof 石药集团中奇制药技术(石家庄)有限公司 2023-12-01 — — CN disclosed
WO-2023186069-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 石药集团中奇制药技术(石家庄)有限公司 2023-10-05 — — WO disclosed
Send feedback